Published in Clin Med Insights Cardiol on July 08, 2015
Cardiac amyloidosis mimicking severe aortic valve stenosis - a case report demonstrating diagnostic pitfalls and role of dobutamine stress echocardiography. BMC Cardiovasc Disord (2017) 0.75
Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging. Can J Cardiol (2016) 0.75
Heart Failure: An Exploration of Recent Advances in Research and Treatment (A). Clin Med Insights Cardiol (2015) 0.75
Molecular mechanisms of amyloidosis. N Engl J Med (2003) 7.75
Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med (1996) 6.57
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest (2004) 4.54
Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation (1978) 4.45
Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med (1977) 4.34
Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med (2013) 3.97
Diagnosis and management of the cardiac amyloidoses. Circulation (2005) 3.96
Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med (1997) 3.65
Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology (2012) 3.48
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol (2004) 3.43
Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol (2007) 3.33
Restrictive cardiomyopathy. N Engl J Med (1997) 3.29
Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging (2010) 3.03
Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol (2005) 2.93
Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation (2009) 2.85
Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol (2011) 2.82
Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol (2004) 2.59
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation (2007) 2.50
Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci (1976) 2.47
On T2* magnetic resonance and cardiac iron. Circulation (2011) 2.33
Screening for hemochromatosis. N Engl J Med (1993) 2.32
HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm (2014) 2.24
Updates in cardiac amyloidosis: a review. J Am Heart Assoc (2012) 2.21
(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging (2013) 2.20
Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest (2002) 2.17
Heart transplantation for end-stage heart failure due to cardiac sarcoidosis. Transplant Proc (2013) 2.15
Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol (2001) 2.03
Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging (2010) 1.93
Amyloid heart disease. Prog Cardiovasc Dis (2010) 1.91
Cardiac sarcoidosis. Am Heart J (2008) 1.89
Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis. Blood (2012) 1.88
Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol (2012) 1.87
Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis. Jpn Circ J (1980) 1.87
Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol (2007) 1.85
Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. Am Heart J (2004) 1.84
Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA (2009) 1.75
Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. JAMA (2013) 1.69
Amyloidosis and the heart: a comprehensive review. Arch Intern Med (2006) 1.68
Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol (2005) 1.65
Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J (1999) 1.62
Cardiac sarcoidosis: a comprehensive review. Arch Med Sci (2011) 1.61
Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging (2007) 1.58
Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol (2005) 1.55
Epidemiology of sarcoidosis in Japan. Eur Respir J (2007) 1.54
Iron-mediated cardiovascular injury. Vasc Med (1999) 1.52
Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol (1987) 1.49
Transthyretin (TTR) cardiac amyloidosis. Circulation (2012) 1.40
CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging (2013) 1.39
Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol (1989) 1.38
Cardiac iron across different transfusion-dependent diseases. Blood Rev (2008) 1.37
Clinical and genetic study of Friedreich ataxia in an Australian population. Am J Med Genet (1999) 1.37
Cardiac sarcoidosis. Heart (2006) 1.34
Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol (2012) 1.31
Digoxin sensitivity in amyloid cardiomyopathy. Circulation (1981) 1.28
Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart (2011) 1.26
Infiltrative cardiovascular diseases: cardiomyopathies that look alike. J Am Coll Cardiol (2010) 1.23
Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives. Circ Heart Fail (2010) 1.19
Left ventricular diastolic Doppler characteristics in beta-thalassemia major. Circulation (1993) 1.19
Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy. Amyloid (2012) 1.16
Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosis. Am J Med (2005) 1.15
Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol (1989) 1.15
Clinical features of Friedreich ataxia. J Child Neurol (2012) 1.14
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis (2014) 1.12
Iron overload cardiomyopathy: better understanding of an increasing disorder. J Am Coll Cardiol (2010) 1.11
Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation (1997) 1.10
Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation (2007) 1.10
Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy. AJR Am J Roentgenol (2009) 1.10
The functional defect in amyloid heart disease. The "stiff heart" syndrome. Am J Cardiol (1975) 1.09
Amyloid neuropathies. Mt Sinai J Med (2012) 1.08
Iron overload cardiomyopathy in clinical practice. Circulation (2011) 1.08
Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS). Am Heart J (2012) 1.07
Endomyocardial biopsy in hemochromatosis: clinicopathologic correlates in six cases. J Am Coll Cardiol (1989) 1.05
Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol (2011) 1.04
The conduction system in cardiac amyloidosis. Clinical and pathologic features of 23 patients. Am J Med (1977) 1.03
Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis. Am J Cardiol (1996) 1.01
Novel Lamp-2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease. Muscle Nerve (2006) 1.00
Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure. Transplantation (2007) 1.00
Marked variation in the cardiomyopathy associated with Friedreich's ataxia. Heart (1999) 1.00
Differentiating cardiac amyloidosis and hypertrophic cardiomyopathy by use of three-dimensional speckle tracking echocardiography. Echocardiography (2012) 0.99
Why are some amyloidoses systemic? Does hepatic "chaperoning at a distance" prevent cardiac deposition in a transgenic model of human senile systemic (transthyretin) amyloidosis? FASEB J (2012) 0.96
Fibrosis: a key feature of Fabry disease with potential therapeutic implications. Orphanet J Rare Dis (2013) 0.95
Ischemic heart disease secondary to amyloidosis of intramyocardial arteries. Am J Cardiol (1979) 0.95
Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization. J Am Coll Cardiol (2006) 0.94
Hereditary hemochromatosis. Am Fam Physician (2013) 0.93
Electrocardiographic changes in early recognition of Fabry disease. Heart (2011) 0.90
Cardiomyopathy of Friedreich ataxia. J Neurochem (2013) 0.90
Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transplant (2007) 0.90
Morphologic and functional characteristics of the heart in Friedreich's ataxia. Am J Med (1987) 0.89
Fine-needle aspiration of abdominal fat pad for amyloid detection: a clinically useful test? Diagn Cytopathol (2004) 0.88
Cardiomyopathy in Friedreich's ataxia: a Doppler-echocardiographic study. Eur Heart J (1992) 0.88
Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis. Am J Cardiol (1997) 0.88
Echocardiographic evaluation of cardiac amyloid. Curr Cardiol Rep (2010) 0.86
Cardiac involvement in hemochromatosis. Cardiol Rev (2014) 0.85
Combined heart and liver transplantation: a single-center experience. Transplantation (2009) 0.84
Selective binding of nifedipine to amyloid fibrils. Am J Cardiol (1985) 0.84
Cardiac amyloidosis presenting with elevations of cardiac troponin I and angina pectoris. Clin Cardiol (2002) 0.84
Symptomatic conduction system disease in cardiac amyloidosis. Am J Cardiol (1997) 0.84
Pathophysiology and treatment of cardiac amyloidosis. Nat Rev Cardiol (2014) 0.83
Management of cardiac sarcoidosis in the United States: a Delphi study. Chest (2011) 0.83
Contemporary outcome of unplanned right ventricular assist device for severe right heart failure after continuous-flow left ventricular assist device insertion. Interact Cardiovasc Thorac Surg (2017) 0.75
Outcome of heart transplantation after bridge-to-transplant strategy using various mechanical circulatory support devices. Interact Cardiovasc Thorac Surg (2017) 0.75